Company Overview of Taivex Therapeutics Corporation
Taivex Therapeutics Corporation, a drug discovery company, researches, develops, and manufactures anti-cancer drugs. It offers a technology platform of to identify compounds that inhibit the Hec1-Nek2 interactions found to be over-expressed in various cancer cells. The company was founded in 2009 and is based in Taipei, Taiwan. Taivex Therapeutics Corporation operates as a subsidiary of Tsou Seen Chemical Industries Corporation.
No. 3, Yuanqu Street
Founded in 2009
886 2 2655 8300
886 2 2655 8315
Key Executives for Taivex Therapeutics Corporation
Taivex Therapeutics Corporation does not have any Key Executives recorded.
Similar Private Companies By Industry
|Amaran Biotechnology, Inc.||Asia|
|Anteluo Biological Technology Co., Ltd.||Asia|
|Aviles Bio-Technology Co., Ltd.||Asia|
|Cathay Biotech Co., Ltd.||Asia|
|Century Hill Enterprises Ltd.||Asia|
Recent Private Companies Transactions
November 22, 2016
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Taivex Therapeutics Corporation, please visit www.taivex.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.